CLINICAL_TRIALS
trial_result
· 2017-04-06
Clinical Trial Update: uPAR PET/CT for Preoperative Staging of Breast Cancer Patients [Phase 2]
Summary
Phase 2 clinical trial evaluating uPAR-targeted PET/CT imaging for preoperative staging in breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED